Log inSign up
Reading a stock page
  • The tabs show the price chart, results, shareholding, events and news for this one company.
  • The Signal Score sums up trend, momentum and quality from past data. It is a description, not a forecast.
  • Every figure names its source. "Official" means it came from NSE or BSE filings.
  • Use the star to watch the stock, or Add to portfolio to record a trade.

Prices during market hours are delayed by up to 15 minutes. Nothing here is a recommendation to buy or sell.

« Dashboard

APLLTD ☆ NSE also on BSE

ALEMBIC PHARMA LTD · code 25328 · INE901L01018 · Pharma & Healthcare · series EQ · Daily price history

1,040.95 -8.65 (-0.82%) close on 20 Nov 2026
Official NSE & BSE Auto-Sync: Checking Overview, Financials, Technicals, Shareholding & Events in the background...
81

ISA Signal Score: Strong setup

Buy candidate: research it further. Based on prices to 2026-11-20. Confidence 100%.

Trend100
Momentum76
52-week range96
Volume85
Risk57
Fundamentals75

Working for it

  • Price is above its 20-day average
  • Price is above its 50-day average
  • Price is above its 200-day average (long-term uptrend)
  • 50-day average is above the 200-day average
  • 50-day average is rising
  • Up 27% in 3 months

Measured reference levels (not forecasts): 20-day low 760.10, 52-week high 1,057.10, typical daily move 47.00, two typical moves below price 946.94.

A rule-based reading of price, volume and filed numbers. It is information, not investment advice, and it can be wrong. Do your own research.

At a glance

Five quick readings from results and prices. A starting point for your own research, not advice.
QualityAverageROE 12.4%, ROCE 11.6%, debt 0.25x equity
GrowthSteadySales 8.5%, profit 6.5% a year over 4 years
ValuationCheapP/E 30.3 vs sector median 50.7
MomentumStrongAbove its 200-day average, beat NIFTY 50 by 17.2 points
RiskMediumSwings 31% a year, fell up to 29% from a peak, beta 0.94

Smart Investor Tips: APLLTD

Constructive Setup (Trend + Fundamentals Aligned)

Actionable Insights & Positives

  • Attractive relative valuation: P/E of 30.3x is at a discount to the sector median of 50.7x.
  • Tip: Click the star button above to add this stock to your Watchlist and set a target "Buy below" alert price.

Risk Checks & Things to Verify

  • Price is stretched 21.0% above its 50-day average (Rs 860.16). Staggering entries on pullbacks toward the 20-day/50-day average lowers entry risk.
  • RSI is elevated at 75 (overbought territory > 70). Avoid chasing gap-ups; let momentum cool or consolidate.
  • High 30-day annualized volatility (49%). Keep initial position sizes smaller and use wider stop-review levels.

NSE MCP Live & 5-Year Check No API Key

Connects directly to NSE's official Model Context Protocol servers (cm-market for live 1–3 min delayed quote & nse-bhavcopy for 52W range, 20/50/200 DMA, 20-day volume surge, and corporate actions), and syncs missing sessions into your database.

Algorithmic Momentum Prediction & Optimal Entry PriceWAIT FOR PULLBACK (BUY ON DIPS) (Score 80/100)

Trend is strong (+21.0% above 50-DMA), so chasing at Rs 1,040.95 carries pullback risk. Better entry price: wait for a dip into Rs 851.56 – Rs 920.37 (near 20/50-DMA), with review stop at Rs 730.41 and target Rs 1,165.98.

Optimal Support areaTranche 1 (50%)Tranche 2 (50%)Risk level / ReviewLevel 1 (Swing)Level 2 (Breakout)Risk : Reward
Rs 851.56 – Rs 920.37
Ideal ~Rs 885.97
Rs 920.37 Rs 851.56 Rs 730.41
ATR 4.5%
Rs 1,165.98 Rs 1,352.65 1 : 1.8
RSI 85 · Vol 3.11x
1M 3M 6M 1Y 3Y ALL Investment checklist Download CSV 6M change +43.7% · high 1,075.00 · low 706.90 · max drawdown -12.0%

Live Candlestick & TradingView Chart (APLLTD)

MARKET CLOSED - EOD SNAPSHOT
Style:  Timeframe:  Overlays:

Key figures results FY26, price 20 Nov

P/E30.3sector median 50.7
P/B-price / book value
EPSRs 34.33grew 6.7% a year
Dividend yield-from saved dividend events
Debt to equity0.25xnet debt Rs 1,430 Cr
Sales growth8.5%a year over 4 years
Profit growth6.5%a year over 4 years
Operating margin15.3%net margin 9.1%

From the official NSE results filings, consolidated. P/E uses the last full year's EPS, PEG 4.64. See all years.

Company Debt, Borrowings & Cash Flow Health (Official FY26 Consolidated Filing)

Auto-extracted from official NSE/BSE XBRL Balance Sheet & Cash Flow statements (Rs Crore).

Strong Balance Sheet & Cash Flow · Score 87/100
Total Debt / Loans Rs 1,430 Cr Increased +Rs 172 Cr YoY
Cash & Bank Balances - Liquid cash & equivalents
Net Debt (Loans − Cash) Rs 1,430 Cr 16.3% of total assets
Debt to Equity & Interest Cover 0.25x D/E Interest cover: 8.4x EBIT
Operating Cash Flow (OCF) Rs 783 Cr OCF/PAT conversion: 117%
Free Cash Flow (FCF) - OCF minus Capex
  • Low Debt-to-Equity (0.25x).
  • Strong loan interest coverage (8.4x EBIT/Interest).
  • High earnings quality: Operating Cash Flow converts 108% of net profit into real cash.

About ALEMBIC PHARMA

No company description saved yet. Use Profile below to read about this company.

Listed on BSE NSE

Market capNot available
First listed20 Sep 2011BSE not available · NSE 20 Sep 2011
Face valueRs 2
Book valueNot available
ROENot availableReturn on equity
ROCENot availableReturn on capital employed

NSE: listing date, face value

Profile completeness2 of 8Missing: description, industry, share count, book value, ROE, ROCE

Checked: NSE results 19 Nov 2026.

Profile, History and Financial records open a web search for this company in a new tab.

Shareholding

Promoters and group 69.87% 0.00 pp, public 30.13%, as on 30 Sep 2026. Holder names and history

Day range1,034.90 to 1,053.80Open 1,045.55
52-week high1,075.00 -3.2% from high (16 Nov 2026)
52-week low635.80 +63.7% from low (23 Mar 2026)
Volume1.91 L 0.3x the 20-day average
RSI (14)75 overbought
Volatility (30d)48.8%annualised
635.80
1,075.00

Returns

1W+1.0%
1M+32.1%
3M+26.7%
6M+37.7%
1Y+15.7%
YTD+23.0%
3Y a year+11.6%
5Y a year+6.5%

Against the NIFTY 50

PeriodAPLLTDNIFTY 50Difference
1M+32.1%+13.1% +19.0 pts
3M+26.7%+6.4% +20.3 pts
6M+37.7%+8.8% +29.0 pts
1Y+15.7%-1.5% +17.2 pts

Risk over the past year

Volatility31%medium
Deepest fall-29.3%from a peak
Beta0.94moves with the index
Best day+12.9%04 Nov 2026
Worst day-7.6%18 May 2026
Up days49%of sessions

Returns use closing prices. Bonus issues and splits are adjusted automatically when detected. Beta compares daily moves with the NIFTY 50 over 246 shared sessions.

AI analysis

Company turnover, products, risks and entry ideas, written by the AI provider you set up in Settings.

Open AI analysis

🛡 Forensic Financial Health: Piotroski F-Score & 3-Step DuPont ROE Decomposition

Institutional balance-sheet quality, earnings-to-cash conversion, and ROE driver breakdown from official XBRL filings.

Piotroski F-Score: 8 / 9 · Fortress Balance Sheet
3-Step DuPont ROE Identity: Balanced Profitability & Efficiency
Net Margin: 9.1% × Asset Turnover: 0.84x × Equity Multiplier: 1.54x = ROE 12.4%
✓ Positive Net Profit (PAT > 0) Rs 671 Cr
✓ Positive Operating Cash Flow (OCF > 0) Rs 783 Cr
✓ High Cash Conversion (OCF >= 85% of PAT) 117% conversion
✓ Improving Return on Assets (ROA YoY) 7.7% vs 7.5%
✓ Conservative / Decreasing Debt-to-Equity 0.25x (prev 0.24x)
✓ Healthy Balance Sheet Asset Coverage 5.29x
⚠ Institutional Return on Equity (ROE >= 14%) 12.4%
✓ Stable / Expanding Profit Margin YoY 9.1% vs 8.7%
✓ Asset Turnover Efficiency (Sales / Assets) 0.84x

Quarterly Results (Last 8 Quarters — QoQ & YoY Acceleration) Rs crore

Rs crore Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales / Revenue 1,4061,7701,7111,9101,8761,8482,1502,603
Sales QoQ % -11.0%+25.9%-3.3%+11.6%-1.8%-1.5%+16.3%+21.1%
Operating Profit 180272282316292229333562
Operating Margin (OPM %) 12.8%15.4%16.5%16.5%15.6%12.4%15.5%21.6%
Net Profit (PAT) 85.8157154184132202172334
Profit QoQ % -48.2%+83.0%-1.9%+19.5%-28.3%+53.0%-14.9%+94.2%
Profit YoY % -63.2%-22.2%-12.6%+11.0%+53.8%+28.7%+11.7%+81.5%
Net Margin % 6.1%8.9%9.0%9.6%7.0%10.9%8.0%12.8%

Sales and profit Rs crore, consolidated

Sales growth+8.5%a year, 4Y
Profit growth+6.5%a year, 4Y
EPS growth+6.7%a year, 4Y
Avg ROE10.9%5 years

Profit and loss

Rs croreFY22FY23FY24FY25FY26
Sales5,3065,6536,2296,6727,345
Sales growth-+6.5%+10.2%+7.1%+10.1%
Operating profit8747089331,0091,121
Operating margin16.5%12.5%15.0%15.1%15.3%
Other income56.02.7428.356.0-14.0
Interest18.050.256.279.094.0
Depreciation287275273279319
Profit before tax625386633707694
Tax rate17.0%3.3%2.5%18.0%3.0%
Net profit521342616582671
Profit growth--34.4%+80.1%-5.5%+15.3%
Net margin9.8%6.1%9.9%8.7%9.1%
EPS (Rs)26.5017.4031.3329.6834.33

Balance sheet

Rs croreFY22FY23FY24FY25FY26
Equity (net worth)5,2374,3704,8185,1915,675
Borrowings7176364301,2581,430
Cash-82.3127--
Total assets7,1226,1836,4467,7738,763
Debt to equity0.14x0.15x0.09x0.24x0.25x

Debt, Loans, Cash Flow & Working Capital

Rs croreFY22FY23FY24FY25FY26
Operating Cash Flow (OCF)55272480388.0783
Capital Expenditure (Capex)-443327--
Free Cash Flow (FCF = OCF - Capex)-281476--
OCF / Net Profit Conversion1.06x2.12x1.30x0.15x1.17x
Total Borrowings / Loans7176364301,2581,430
Cash & Bank Balances-82.3127--
Trade Receivables (Cr)-1,0461,025--
Receivable Days-67.57x60.06x--
Inventories (Cr)-1,4751,644--
Inventory Days-95.26x96.31x--

Returns on capital

Rs croreFY22FY23FY24FY25FY26
ROE9.9%7.1%13.4%11.6%12.4%
ROCE10.8%8.3%14.4%13.7%11.6%
Interest cover35.72x8.68x12.26x9.95x8.38x

Read from the official annual results filed with NSE (XBRL), consolidated figures. ROE uses average equity of the year and the year before when both are saved, ROCE uses profit before interest and tax over total assets less current liabilities. EPS is per today's share. Check the annual report before investing.

Compared with its sector Pharma & Healthcare

StockPriceDay1 yearMkt cap (Cr)P/EP/BROENet margin
LAURUSLABSLAURUS LABS LIMITED 2,294.60 -0.5% - 123,667 139.4 23.3 16.8% 13.1%
ZYDUSLIFEZYDUS LIFESCIENCES LTD 1,200.00 -0.2% - 120,720 31.5 6.1 0.6% 0.6%
GLENMARKGLENMARK PHARMACEUTICALS 2,648.00 +1.5% - 74,724 - 9.5 -19.1% -12.7%
FORTISFORTIS HEALTHCARE LTD 825.00 +1.9% - 62,284 59.8 - 7.8% 11.7%
GLANDGLAND PHARMA LIMITED 3,331.90 +1.2% - 54,880 53.4 - 8.9% 16.0%
GLAXOGLAXOSMITHKLINE PHARMA LT 2,727.60 +0.5% - 46,208 78.3 26.0 33.2% 17.1%
EMCUREEMCURE PHARMACEUTICALS L 2,337.80 -0.3% - 44,351 47.9 9.0 19.0% 10.2%
SAILIFESAI LIFE SCIENCES LIMITED 1,800.70 +0.7% - 38,250 109.3 15.4 14.0% 15.9%
WOCKPHARMAWOCKHARDT LIMITED 2,184.40 -0.1% - 35,495 166.5 7.2 4.3% 6.4%
GRANULESGRANULES INDIA LIMITED 822.65 +2.7% - 19,939 34.3 3.9 11.7% 11.1%
ALIVUSALIVUS LIFE SCIENCES LTD 1,436.90 -0.9% - 17,609 37.4 7.6 20.2% 20.6%
CAPLIPOINTCAPLIN POINT LAB LTD. 2,029.10 -2.7% - 15,411 33.7 6.7 19.7% 27.0%
APLLTDALEMBIC PHARMA LTD 1,040.95 -0.8% - - 30.3 - 11.8% 9.1%
Sector median- 50.77.012.4%

The 13 largest of 80 stocks in this sector on NSE, by market cap where known and traded value otherwise. Valuation shows for stocks whose results this site has read; it fills in as people open more stock pages. Prices from 20 Nov 2026.

Today: 15 minute chart and signal

Opens when you view this tab.

Analysis and next-session reading

Opens when you view this tab.

Complete analysis report Financials, shareholding, events, risks and a data reliability score.

Signals

Price is above its 50-day average 20-day average is above the 50-day (short-term uptrend) Price is above its 200-day average (long-term uptrend) RSI 75: overbought zone, a pullback is more likely

Simple rules applied to end-of-day prices. They describe what the chart is doing and are not advice to buy or sell.

When is a good price? from this stock's own price history

The price is in the upper quarter of its 1-year range and is lower than it was on 2% of days in the past year.

Support (prices below today's)

50-day average860.16-17.4%
200-day average791.77-23.9%
20-day low748.25-28.1%
60-day low748.25-28.1%
52-week low635.80-38.9%

Resistance (prices above today's)

20-day high1,075.00+3.3%
60-day high1,075.00+3.3%
52-week high1,075.00+3.3%

Zones buyers often watch

Lower quarter of the 1-year range 635.80 to 745.60 Historically the cheapest part of the past year.
Pullback of 10% to 20% from the high 860.00 to 967.50 A common area for dips inside an uptrend.
Around the 200-day average 768.02 to 815.52 Long-term trend line, often watched as support.

Deepest fall from a peak in the past year: -29.3%. Currently -1.5% below its latest peak. Levels are from history and do not predict where the price will go.

Moving averages and momentum

IndicatorValueReading
20-day average920.37 Price is 13.1% above
50-day average860.16 Price is 21.0% above
200-day average791.77 Price is 31.5% above
RSI (14)75Overbought zone
MACD (12, 26, 9)65.59Above its signal line (momentum rising)
Volatility (30d)48.8%High yearly swings

Support and resistance

R21,062.12
R11,051.53
Pivot1,043.22
S11,032.63
S21,024.32

Classic pivot levels from the latest session's high, low and close. Prices often pause near them, but they are only reference points.

DateOpenHighLow CloseChangeVolume
2026-11-20 1,045.55 1,053.80 1,034.90 1,040.95 -0.82% 191,247
2026-11-19 1,044.35 1,054.25 1,038.50 1,049.60 +0.50% 333,407
2026-11-18 1,041.00 1,060.00 1,041.00 1,044.35 -0.60% 228,735
2026-11-17 1,058.10 1,062.45 1,045.00 1,050.65 -0.61% 201,850
2026-11-16 1,033.50 1,075.00 1,033.50 1,057.10 +2.62% 452,099
2026-11-13 1,049.00 1,073.00 1,024.15 1,030.15 -1.63% 422,868
2026-11-12 1,037.00 1,055.00 1,030.15 1,047.25 +1.68% 452,715
2026-11-11 1,023.00 1,051.50 1,021.15 1,029.95 +1.24% 540,258
2026-11-09 1,015.10 1,055.70 1,006.30 1,017.30 +0.72% 980,734
2026-11-06 894.80 985.00 890.00 965.15 +8.02% 2,367,580
2026-11-05 919.70 936.95 885.60 893.50 -1.46% 1,927,181
2026-11-04 808.00 963.35 803.65 906.70 +12.94% 4,162,581
2026-11-03 803.00 814.85 798.50 802.80 -0.02% 92,294
2026-11-02 801.10 806.70 786.50 803.00 +0.65% 97,135
2026-10-30 794.85 800.00 784.05 797.85 +0.38% 72,865
2026-10-29 780.40 801.00 776.00 794.85 +1.54% 63,490
2026-10-28 769.95 788.00 765.90 782.80 +2.07% 125,417
2026-10-27 762.55 779.00 761.80 766.90 +0.07% 203,141
2026-10-26 759.45 769.55 753.55 766.40 +0.83% 43,824
2026-10-23 775.00 776.00 748.25 760.10 -2.71% 120,847
2026-10-22 779.00 786.95 777.15 781.30 -0.84% 45,524
2026-10-21 794.20 794.70 781.30 787.95 -0.30% 61,315
2026-10-19 790.05 799.00 779.00 790.35 +0.11% 137,411
2026-10-16 792.65 793.00 771.00 789.45 -0.40% 148,103
2026-10-15 797.95 802.40 789.25 792.65 +0.03% 77,862
2026-10-14 789.05 799.15 785.80 792.45 -0.68% 70,461
2026-10-13 787.10 800.00 778.85 797.85 +1.12% 70,432
2026-10-12 796.95 806.00 786.20 789.05 -1.49% 110,567
2026-10-09 801.00 806.20 788.75 800.95 +0.06% 187,843
2026-10-08 833.80 835.10 797.95 800.50 -3.99% 171,505
2026-10-07 834.10 839.00 821.25 833.80 -0.05% 135,889
2026-10-06 831.25 840.30 825.00 834.20 +0.35% 143,011
2026-10-05 815.25 836.80 812.20 831.25 +1.96% 282,527
2026-10-01 816.00 827.85 803.50 815.25 -1.24% 327,528
2026-09-30 866.00 876.40 821.70 825.45 -4.18% 266,145
2026-09-29 853.90 868.00 837.50 861.50 +0.84% 457,488
2026-09-28 870.00 870.00 843.65 854.35 -1.09% 211,650
2026-09-25 855.00 869.80 840.55 863.75 +1.62% 309,225
2026-09-24 840.00 858.40 834.95 850.00 +0.66% 354,230
2026-09-23 837.00 860.00 837.00 844.40 +0.51% 146,755
2026-09-22 847.05 850.95 835.90 840.15 -1.01% 104,047
2026-09-21 845.75 867.85 845.00 848.75 +0.35% 242,136
2026-09-18 828.00 860.00 828.00 845.75 +2.39% 634,938
2026-09-17 830.00 857.25 819.60 826.00 +0.08% 392,626
2026-09-16 817.30 839.95 813.20 825.30 +0.07% 136,463
2026-09-15 811.00 839.35 810.20 824.75 +1.70% 165,473
2026-09-11 806.00 822.00 799.20 810.95 -0.67% 118,504
2026-09-10 818.55 836.50 813.80 816.40 -0.12% 119,529
2026-09-09 804.50 821.50 799.10 817.40 +1.10% 86,236
2026-09-08 802.00 810.95 792.60 808.50 +1.12% 200,271
2026-09-07 808.00 828.10 797.40 799.55 -1.07% 171,275
2026-09-04 805.00 811.75 792.60 808.20 +0.57% 174,296
2026-09-03 833.50 833.50 801.10 803.65 -2.81% 163,761
2026-09-02 845.00 859.00 823.25 826.90 -2.01% 172,875
2026-09-01 835.00 847.85 825.55 843.85 +1.07% 114,428
2026-08-31 813.00 839.90 808.60 834.90 +2.64% 139,739
2026-08-28 824.00 828.45 811.10 813.45 -1.28% 89,882
2026-08-27 825.00 848.95 816.10 824.00 -0.10% 285,845
2026-08-26 805.15 828.85 805.15 824.80 +2.70% 50,380
2026-08-25 816.90 820.00 801.05 803.10 -1.69% 37,809
2026-08-24 819.00 826.00 810.20 816.90 -0.59% 39,308
2026-08-21 815.00 826.80 815.00 821.75 +0.94% 35,565
2026-08-20 817.90 826.45 810.05 814.10 -0.42% 47,603
2026-08-19 823.15 824.40 806.25 817.50 -0.86% 98,543
2026-08-18 820.00 838.00 820.00 824.55 +0.26% 51,271
2026-08-17 824.80 827.80 812.30 822.45 -1.06% 90,276
2026-08-14 832.20 834.40 815.40 831.25 +0.01% 86,735
2026-08-13 844.00 847.50 828.00 831.20 -1.24% 44,236
2026-08-12 838.85 852.60 833.00 841.65 +0.33% 142,034
2026-08-11 831.35 849.00 823.85 838.85 +0.90% 217,637
2026-08-10 834.00 855.90 827.10 831.35 +0.15% 83,817
2026-08-07 835.00 851.85 825.50 830.10 -0.52% 156,108
2026-08-06 818.20 838.40 817.15 834.45 +1.99% 210,314
2026-08-05 822.00 840.40 803.20 818.20 +1.09% 243,621
2026-08-04 805.75 825.00 799.10 809.40 +0.45% 485,095
2026-08-03 797.05 815.05 792.55 805.75 +1.09% 58,590
2026-07-31 802.75 805.85 793.25 797.05 -0.71% 50,542
2026-07-30 805.45 808.25 800.05 802.75 -1.13% 46,368
2026-07-29 815.00 818.25 802.60 811.95 -0.84% 81,697
2026-07-28 815.80 828.00 810.35 818.85 +0.54% 74,793
2026-07-27 824.00 824.00 802.05 814.45 +2.11% 50,274
2026-07-24 789.00 803.10 787.40 797.60 -0.09% 36,166
2026-07-23 805.00 819.00 793.40 798.35 -1.71% 63,082
2026-07-22 833.60 833.65 810.00 812.20 -2.57% 57,507
2026-07-21 842.65 843.00 830.55 833.60 -1.07% 46,223
2026-07-20 827.00 849.90 825.35 842.65 +2.13% 81,589
2026-07-17 842.85 842.85 821.00 825.10 -1.74% 70,744
2026-07-16 851.00 855.40 837.10 839.75 -1.21% 92,763
2026-07-15 817.10 853.95 817.10 850.05 +3.52% 207,604
2026-07-14 820.00 834.75 811.05 821.15 -1.19% 122,575
2026-07-13 840.00 845.00 825.00 831.05 -0.76% 101,420
2026-07-10 824.00 839.85 815.55 837.40 +2.51% 109,731
2026-07-09 818.45 830.00 809.35 816.90 +0.69% 62,063
2026-07-08 829.40 842.80 801.25 811.30 -2.18% 150,088
2026-07-07 838.00 841.95 824.30 829.35 -0.75% 81,550
2026-07-06 829.50 839.00 821.30 835.65 +1.45% 226,133
2026-07-03 825.00 834.15 809.50 823.70 +0.66% 143,213
2026-07-02 829.00 840.00 808.90 818.30 -1.30% 116,150
2026-07-01 843.20 846.00 813.30 829.05 +0.77% 247,683
2026-06-30 788.20 832.05 784.15 822.75 +4.59% 919,045
2026-06-29 778.10 790.05 773.10 786.65 +1.96% 139,448
2026-06-25 780.65 783.00 765.10 771.50 -1.17% 21,774
2026-06-24 771.00 784.55 770.05 780.65 +0.47% 34,075
2026-06-23 784.80 792.85 775.00 777.00 -0.48% 53,280
2026-06-22 763.00 800.00 763.00 780.75 +2.33% 222,284
2026-06-19 749.70 768.80 744.35 763.00 +1.77% 279,321
2026-06-18 749.70 753.00 742.00 749.70 +0.48% 54,614
2026-06-17 747.95 753.65 742.20 746.15 +0.06% 45,282
2026-06-16 742.00 748.90 735.55 745.70 +1.08% 54,805
2026-06-15 750.00 753.70 736.10 737.75 -0.75% 59,045
2026-06-12 749.25 754.45 738.30 743.35 +1.18% 86,226
2026-06-11 737.20 759.20 729.50 734.65 -0.35% 311,704
2026-06-10 733.95 752.40 732.65 737.20 +0.78% 223,213
2026-06-09 750.00 750.00 725.35 731.50 -1.88% 231,744
2026-06-08 742.75 754.15 732.65 745.50 +0.96% 449,802
2026-06-05 740.00 745.45 727.60 738.40 +0.12% 98,111
2026-06-04 717.40 747.85 717.40 737.55 +1.93% 636,136
2026-06-03 721.15 728.00 710.60 723.55 -0.27% 68,595
2026-06-02 723.70 729.00 706.90 725.50 +0.76% 41,803
2026-06-01 736.00 738.90 713.40 720.00 -2.19% 78,215
2026-05-29 754.95 760.65 724.95 736.10 -2.40% 134,388
2026-05-27 763.95 763.95 749.00 754.20 -0.71% 49,295
2026-05-26 762.30 780.75 757.00 759.60 -0.35% 132,923
2026-05-25 764.95 764.95 753.00 762.30 +0.87% 91,871
2026-05-22 754.50 765.00 743.65 755.70 +0.91% 192,689
2026-05-21 755.85 756.10 745.00 748.90 -0.46% 98,559
2026-05-20 751.10 762.25 736.55 752.35 +0.17% 68,947
2026-05-19 728.00 768.50 727.55 751.10 +3.69% 220,439
2026-05-18 780.00 782.10 710.70 724.40 -7.61% 327,979

News from the last 15 days More

Shareholding pattern

Up to dateNSE listingChecks passed

Quarter ended 30 Sep 2026, filed 16 Oct 2026. Latest filing is for the expected quarter (Sep 2026). Company: ALEMBIC PHARMA LTD, ISIN INE901L01018.

Promoters and group
69.87%
0.00 pp vs Jun 2026
Public (all, Category B)
30.13%
0.00 pp vs Jun 2026

Foreign, domestic institution and mutual fund lines need the filing file for the period. An admin can load them under Admin > Shareholding tracker.

Ownership split

Trend

Latest quarter compared

CategoryPrevious (Jun 26)Latest (Sep 26)Change (pp)Change in sharesYear earlier (pp)What it may mean
Promoters and group69.87%69.87%0.00 pp-+0.13 ppNo material change.
Public (all, Category B)30.13%30.13%0.00 pp--0.13 ppNo material change.

Change is in percentage points (latest percent minus previous percent), not a relative change. Mutual funds and insurers are part of domestic institutions and are never added to it. Only comparable quarters (1 to 6 months apart; about a year for the year-earlier column) are compared.

Insights and risk alerts

No rule was triggered by the data in the database. That is not a clean bill of health: the rules look only at reported holdings.

These alerts describe reported ownership. They are not buy or sell advice. Judge the company with its results, debt, valuation and announcements.

Who holds the shares

The exchange listing has no filing file for this stock, so holder names are not available.

Quarter by quarter

Quarter endedPromotersChangePublicChangeFiledSource
Sep 202669.87%0.00 pp30.13%0.00 pp16 Oct 2026NSE
Jun 202669.87%+0.13 pp30.13%-0.13 pp15 Jul 2026NSE
Mar 202669.74%0.00 pp30.26%0.00 pp10 Apr 2026NSE
Dec 2025 revised69.74%0.00 pp30.26%0.00 pp09 Jan 2026NSE
Sep 202569.74%+0.07 pp30.26%-0.07 pp14 Oct 2025NSE
Jun 202569.67%0.00 pp30.33%0.00 pp16 Jul 2025NSE
Mar 202569.67%+0.06 pp30.33%-0.06 pp18 Apr 2025NSE
Dec 202469.61%0.00 pp30.39%0.00 pp20 Jan 2025NSE
Sep 202469.61%0.00 pp30.39%0.00 pp10 Oct 2024NSE
Jun 202469.61%0.00 pp30.39%0.00 pp10 Jul 2024NSE
Mar 202469.61%0.00 pp30.39%0.00 pp10 Apr 2024NSE
Dec 202369.61%0.00 pp30.39%0.00 pp10 Jan 2024NSE
Sep 2023 revised69.61%0.00 pp30.39%0.00 pp10 Oct 2023NSE
Jun 202369.61%0.00 pp30.39%0.00 pp07 Jul 2023NSE
Mar 202369.61%0.00 pp30.39%0.00 pp07 Apr 2023NSE
Dec 202269.61%0.00 pp30.39%0.00 pp18 Jan 2023NSE
Sep 202269.61%0.00 pp30.39%0.00 pp11 Oct 2022NSE
Jun 202269.61%0.00 pp30.39%0.00 pp07 Jul 2022NSE
Mar 2022 revised69.61%+0.13 pp30.39%-0.13 pp07 Apr 2022NSE
Dec 202169.48%0.00 pp30.52%0.00 pp07 Jan 2022NSE
Sep 202169.48%-30.52%-06 Oct 2021NSE
Shareholding details

Loading...

Events

Not checked yet

No events saved for this stock yet.

Fetched from NSE automatically and saved on this site, so past events stay available. Ex date is the first day the stock trades without the benefit; a bonus or split is applied to old prices on its own from that day. Confirm on the exchange website before acting.

ISA shows information and signals worked out from past prices and company filings. They are not recommendations to buy, sell or hold any security, and ISA is not a SEBI-registered investment adviser or research analyst. Prices may be delayed. Check with a registered adviser before you invest.